Touchstone
Last syncNov 1, 2026, 6:55 PM ET

HTFL

Heartflow, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$59.05Close $5.0BMarket cap $20.49 – $60.5352-week range Nov 12, 2026Next report · after the close

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 98 · stronger than 98% of stocks over 12 months
  • Near its high 2% below its 52-week high

Cautions

  • Results soon Nov 12, 2026, in 11 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 13, 2026
Off 12-month high 2%
1wk up 4.1% price change
1mo up 18.7% price change
12-month return up 61% market up 11% · its own up 47%
F-score — — Not assessed
Altman Z 47.64 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 16.7× price / book
Earnings yield down 1.3% EBIT / enterprise value
Cheaper than 16% of the market · expensive
Revenue growth up 40% year on year
EPS growth — latest quarter
Sales growth up 48% latest quarter · +6 pts
ROE down 39% return on equity
Free cash margin down 34% -$59.0M FCF
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests

Repair signals

  • Gross margin 75.1% → 76.8%

Trade setup

ATR% 4.9% $2.89 a day · 2×ATR $53.27
RS 98 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.2× vs 50-day average
Up/down volume 0.97 50 sessions
Implied move — no option chain · report Nov 12, 2026
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 1293.0% over the year, from 6m to 85m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Aug 13, 2026
Results reaction Aug 13, 2026+40% vs market2 sessions after results

Financials

3 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $176.0M +40% on FY2024
$0 $200M FY23 FY24 FY25 FY2023 · $87.2M FY2024 · $125.8M FY2025 · $176.0M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$116.8M
-$200M $0 FY23 FY24 FY25 FY2023 · -$95.7M FY2024 · -$96.4M FY2025 · -$116.8M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$59.0M
-$100M $0 FY23 FY24 FY25 FY2023 · -$82.5M FY2024 · -$73.4M FY2025 · -$59.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 77%
  • Net -66%
  • Free cash -34%
-200% 0% 100% FY23 FY24 FY25 FY2023 · Gross 67% · Net -110% · Free cash -95% FY2024 · Gross 75% · Net -77% · Free cash -58% FY2025 · Gross 77% · Net -66% · Free cash -34%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $200M FY23 FY24 FY25 FY2023 · Cash $122.8M FY2024 · Cash $51.4M · Long-term debt $136.4M FY2025 · Cash $44.8M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 85.28m
85.28m 6.12m FY23 FY24 FY25 FY2023 FY2024 · 6.12m FY2025 · 85.28m
  FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $87.2M $125.8M $176.0M
Gross margin 67% 75% 77%
Operating income -$72.9M -$61.2M -$64.1M
Net income -$95.7M -$96.4M -$116.8M
Net margin -110% -77% -66%
Earnings per share -$19.58 -$17.98 -$3.17
Free cash flow -$82.5M -$73.4M -$59.0M
Free cash margin -95% -58% -34%
Cash $122.8M $51.4M $44.8M
Long-term debt — $136.4M —
Shareholders' equity -$777.6M -$859.5M $300.6M
Shares outstanding — 6.12m 85.28m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 13, 2026 Quarterly ↗ Jun 30, 2026 44d
May 14, 2026 Quarterly ↗ Mar 31, 2026 44d
Mar 18, 2026 Annual ↗ Dec 31, 2025 77d
Nov 12, 2025 Quarterly ↗ Sep 30, 2025 43d
Sep 19, 2025 Quarterly ↗ Jun 30, 2025 81d

Current reports

FiledDisclosed
Aug 13, 2026 Results ↗
Jun 18, 2026 Shareholder vote ↗
May 14, 2026 Results ↗
Mar 18, 2026 Results ↗
Jan 12, 2026 Regulation FD ↗
Nov 12, 2025 Results ↗
Sep 10, 2025 Results · Regulation FD ↗
Aug 25, 2025 Agreement ended ↗
Aug 11, 2025 Charter or bylaws · Other events ↗